MNA
MRK icon

Manning & Napier Advisors’s Merck MRK Stock Holding History

Manning & Napier Advisors’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.5M Sell
173,781
-2,500
-1% -$293K 0.29% 63
2026
Q1 		$21.2M Buy
176,281
+768
+0.4% +$88.7K 0.3% 67
2025
Q4 		$18.6M Sell
175,513
-11,241
-6% -$1.06M 0.24% 70
2025
Q3 		$15.7M Sell
186,754
-71,367
-28% -$5.88M 0.2% 67
2025
Q2 		$20.4M Buy
258,121
+189,837
+278% +$15.1M 0.24% 71
2025
Q1 		$6.13M Sell
68,284
-6,332
-8% -$591K 0.08% 153
2024
Q4 		$7.42M Buy
+74,616
New +$7.69M 0.08% 135
2017
Q3 		$29.1M Buy
476,917
+14,719
+3% +$892K 0.25% 75
2017
Q2 		$28.3M Buy
462,198
+60,485
+15% +$3.68M 0.24% 72
2017
Q1 		$24.4M Buy
401,713
+3,861
+1% +$234K 0.19% 73
2016
Q4 		$22.3M Buy
397,852
+45,749
+13% +$2.68M 0.15% 74
2016
Q3 		$21M Sell
352,103
-71,707
-17% -$4.19M 0.13% 71
2016
Q2 		$23.3M Sell
423,810
-101,823
-19% -$5.42M 0.14% 68
2016
Q1 		$26.5M Sell
525,633
-80,960
-13% -$3.97M 0.15% 67
2015
Q4 		$30.6M Sell
606,593
-5,868,336
-91% -$296M 0.18% 70
2015
Q3 		$305M Sell
6,474,929
-176,977
-3% -$9.4M 1.64% 22
2015
Q2 		$361M Buy
6,651,906
+6,234,431
+1,493% +$350M 1.57% 22
2015
Q1 		$22.9M Sell
417,475
-923
-0.2% -$52.3K 0.11% 105
2014
Q4 		$22.7M Buy
418,398
+22,894
+6% +$1.28M 0.1% 110
2014
Q3 		$22.4M Sell
395,504
-2,937
-0.7% -$165K 0.09% 117
2014
Q2 		$22M Buy
398,441
+27,979
+8% +$1.53M 0.09% 118
2014
Q1 		$20.1M Sell
370,462
-58,361
-14% -$3.02M 0.08% 116
2013
Q4 		$20.5M Sell
428,823
-13,482
-3% -$616K 0.09% 109
2013
Q3 		$20.1M Buy
442,305
+2,467
+0.6% +$113K 0.09% 102
2013
Q2 		$19.5M Buy
+439,838
New +$19.6M 0.1% 99

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Manning & Napier Advisors's MRK Position: Q2 2026 in Review

Manning & Napier Advisors reduced its Merck (MRK) stake by 1.4% in Q2 2026, selling an estimated $293K and leaving 173,781 shares worth $22.5M. The position accounts for 0.29% of the portfolio, ranked #63.

Manning & Napier Advisors first reported a position in MRK in Q2 2013 and has held it in 25 quarters since. The position peaked at $361M in Q2 2015. 3,832 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Manning & Napier Advisors held 173,781 shares of Merck worth $22.5M as of Q2 2026.
  • Manning & Napier Advisors sold 2,500 Merck shares in Q2 2026, an estimated $293K.
  • Merck made up 0.29% of Manning & Napier Advisors's portfolio in Q2 2026, its #63 holding.
  • Manning & Napier Advisors first reported a position in Merck in Q2 2013 and has held it in 25 quarters since.
  • Manning & Napier Advisors's Merck position peaked at $361M in Q2 2015.
  • 3,832 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Manning & Napier Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.